Huntington National Bank held its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,434 shares of the real estate investment trust’s stock at the end of the second quarter. Huntington National Bank’s holdings in Medical Properties Trust were worth $147,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in MPW. UBS Asset Management Americas Inc. increased its position in shares of Medical Properties Trust by 13.6% in the fourth quarter. UBS Asset Management Americas Inc. now owns 458,798 shares of the real estate investment trust’s stock worth $5,642,000 after buying an additional 54,835 shares during the period. Teachers Advisors LLC increased its position in shares of Medical Properties Trust by 26.8% in the fourth quarter. Teachers Advisors LLC now owns 2,010,316 shares of the real estate investment trust’s stock worth $24,727,000 after buying an additional 424,494 shares during the period. Macquarie Group Ltd. increased its position in shares of Medical Properties Trust by 3.9% in the fourth quarter. Macquarie Group Ltd. now owns 253,400 shares of the real estate investment trust’s stock worth $3,116,000 after buying an additional 9,400 shares during the period. Raymond James Trust N.A. acquired a new position in shares of Medical Properties Trust during the first quarter worth $154,000. Finally, GW&K Investment Management LLC acquired a new position in shares of Medical Properties Trust during the first quarter worth $148,000. 82.12% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Medical Properties Trust, Inc. (MPW) traded down 0.79% during midday trading on Friday, hitting $12.51. The stock had a trading volume of 2,378,049 shares. The company has a market cap of $4.38 billion, a price-to-earnings ratio of 15.29 and a beta of 0.89. Medical Properties Trust, Inc. has a 52 week low of $11.54 and a 52 week high of $15.74. The stock’s 50-day moving average price is $12.75 and its 200 day moving average price is $13.03.
Medical Properties Trust (NYSE:MPW) last released its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.32 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.32. The company had revenue of $166.80 million during the quarter, compared to the consensus estimate of $163.08 million. Medical Properties Trust had a net margin of 42.25% and a return on equity of 7.54%. Medical Properties Trust’s revenue for the quarter was up 32.1% on a year-over-year basis. During the same period last year, the firm earned $0.32 EPS. On average, equities analysts forecast that Medical Properties Trust, Inc. will post $0.93 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 12th. Investors of record on Thursday, September 14th will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 7.67%. The ex-dividend date of this dividend is Wednesday, September 13th. Medical Properties Trust’s dividend payout ratio (DPR) is presently 115.66%.
ILLEGAL ACTIVITY WARNING: “Huntington National Bank Has $147,000 Stake in Medical Properties Trust, Inc. (NYSE:MPW)” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://www.com-unik.info/2017/08/19/medical-properties-trust-inc-nysempw-position-held-by-huntington-national-bank-updated-updated.html.
MPW has been the topic of a number of recent analyst reports. Royal Bank Of Canada reissued a “buy” rating on shares of Medical Properties Trust in a research report on Monday, May 15th. ValuEngine downgraded Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Jefferies Group LLC reissued a “buy” rating and set a $16.00 price target (up previously from $15.00) on shares of Medical Properties Trust in a research report on Friday, June 9th. BidaskClub raised Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Saturday, June 10th. Finally, Deutsche Bank AG boosted their price target on Medical Properties Trust from $13.50 to $15.00 and gave the stock a “buy” rating in a research report on Tuesday, July 4th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the company. Medical Properties Trust currently has an average rating of “Hold” and an average price target of $14.20.
In related news, CFO R Steven Hamner sold 85,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $13.36, for a total value of $1,135,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.00% of the stock is currently owned by company insiders.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
What are top analysts saying about Medical Properties Trust Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Medical Properties Trust Inc. and related companies.